Financial Data and Key Metrics Changes - The company reported full-year consolidated revenue of $947.7 million, an increase of $252.5 million, or 36.3% year-over-year [6] - Adjusted EBITDA for the full year was $72.5 million, up $19.2 million, or 36% compared to the previous year [6] - Adjusted earnings per share for the full year reached $1.18, exceeding the midpoint of the updated annual guidance of $1.16 [5][6] Business Line Data and Key Metrics Changes - In the home health and hospice segment, Q4 revenue was $233.3 million, an increase of $91.3 million, or 64.3% year-over-year, with adjusted EBITDA of $33.7 million, up $12.4 million, or 58.2% [12] - Fourth quarter admissions surged 81.3%, with Medicare admissions growing 87.5% year-over-year [12] - The senior living segment saw full-year revenue improve to $215 million, an increase of $39.2 million, or 22.3% over the prior year [16] Market Data and Key Metrics Changes - The average daily census in hospice care grew to 5,060, a 46.9% increase over the prior year quarter [15] - Same-store Medicare admissions in home health grew 8.2%, with a 3.7% increase in Medicare revenue per episode [13] - All store occupancy in senior living rose 200 basis points to 80.6%, with same-store occupancy ending the year at 82.1% [17] Company Strategy and Development Direction - The company is focused on optimizing performance and driving operational excellence while remaining open to selective acquisitions [9] - Key focus areas include leadership development, clinical excellence, employee experience, margin improvement, and growth [8] - The company aims to continue the upward trajectory of its senior living business, with significant growth potential ahead [10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the underlying trajectory of the business despite reimbursement headwinds [15] - The company anticipates a full-year revenue guidance of $1.13 billion to $1.17 billion for 2026, reflecting a 22.4% increase at the midpoint [11] - Management highlighted the importance of local leadership in responding to community needs and driving organic growth [57] Other Important Information - The company completed significant acquisitions, including the purchase of over 50 locations from UnitedHealth and Amedisys, enhancing its reach in the Southeast [8] - The balance sheet remains strong, with a net debt to adjusted EBITDA ratio of 1.7 times, well under the covenant limit [23] - The company generated $21 million of cash flows from operations in Q4, bringing the year-to-date total to $48.3 million [23] Q&A Session Summary Question: Is the guidance conservative due to the integration of Amedisys and UnitedHealth? - Management confirmed that the guidance reflects a conservative approach due to expected initial noise during the transition of operations [30] Question: How do joint ventures perform compared to non-JV agencies? - Management stated that joint ventures are treated like any Pennant business, focusing on local leadership and collaboration with health system partners to achieve exceptional outcomes [32] Question: How does the Amedisys and UnitedHealth asset ramp-up compare to Signature? - Management noted similarities in leadership quality and operational strengths, expressing confidence in the transition process based on past experiences [39] Question: What is the expected same-store revenue growth for 2026? - Management indicated a projected 7% increase in home health and hospice revenue for 2026, despite anticipated rate decreases [51] Question: What is the competitive landscape in the hospice segment? - Management highlighted a normalization in growth rates post-pandemic, with strong organic growth driven by local community needs [78]

Financial Data and Key Metrics Changes - The company reported Q4 adjusted earnings per share of $0.24, contributing to a full year adjusted earnings per share of $0.94, exceeding the updated guidance midpoint of $0.93 [11] - Full year consolidated revenue reached $695.2 million, an increase of $150.3 million or 27.6% over the prior year, with adjusted EBITDA of $53.3 million, an improvement of $12.6 million or 30.9% [12][33] - The company generated $20.6 million in net cash from operating activities and $17.2 million in free cash flow during Q4 [36] Business Line Data and Key Metrics Changes - Home health and hospice segment revenue for the full year increased to $519.5 million, a $125 million or 31.7% increase over the prior year, with Q4 revenue at $142 million, a $35.1 million or 32.9% increase [21] - Senior living segment revenue improved to $175.8 million, a $25.3 million or 16.8% increase over the prior year, with Q4 revenue at $46.9 million, a $7.8 million or 20% increase [26] Market Data and Key Metrics Changes - Home health admissions reached a new high of 15,909, an increase of 40.9%, while Medicare admissions increased to 6,443, a 30.1% increase [22] - The average CMS-reported star rating was 4.1, significantly exceeding the national average of 3.0, with a potentially preventable hospitalization rate of 8.7%, better than the national average of 9.9% [24] Company Strategy and Development Direction - The company is focused on five key initiatives: leadership development, employee experience, clinical excellence, margin, and growth, with significant progress made in each area [14] - The company anticipates full-year 2025 revenue in the range of $800 million to $865 million, with adjusted earnings per share projected between $1.03 and $1.11, reflecting a 13.8% growth over 2024 adjusted earnings [19][37] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the growth potential in both segments, driven by local leaders' readiness to drive organic and inorganic growth [19] - The company remains confident in its ability to adapt to potential changes in the legislative funding environment, particularly regarding Medicaid [66] Other Important Information - The company completed numerous strategic acquisitions, including the $80 million purchase of Signature Healthcare at Home, and entered into long-term leases for three senior living communities [13][28] - The company reported a strong focus on leadership development, adding 66 leaders to its CEO training program and launching a clinical leadership training program [16] Q&A Session Summary Question: 2025 outlook and same-store revenue growth expectations - Management projected about a 7% increase in same-store revenue for home health, hospice, and senior living [53] Question: Legislative funding environment and Medicaid exposure - Management indicated that approximately 15% of the business is exposed to potential Medicaid impacts, primarily from senior living [62][66] Question: Guidance assumptions for EBITDA margin improvement - Management expects some impact from recent acquisitions but anticipates home health margins to remain in the high 15% to low 16% range [83] Question: Hospice cap issue and operational changes - Management noted that they are focused on adjusting referral patterns to minimize hospice cap impacts, estimating a potential reduction in cap impact for 2025 [93] Question: Senior living segment and M&A opportunities - Management expressed confidence in the senior living segment's revenue quality and ongoing efforts to optimize the resident mix [99]